1. Home
  2. BAFN vs BCTX Comparison

BAFN vs BCTX Comparison

Compare BAFN & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BayFirst Financial Corp.

BAFN

BayFirst Financial Corp.

N/A

Current Price

$6.53

Market Cap

30.9M

Sector

Finance

ML Signal

N/A

Logo BriaCell Therapeutics Corp.

BCTX

BriaCell Therapeutics Corp.

HOLD

Current Price

$3.79

Market Cap

28.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAFN
BCTX
Founded
1999
2014
Country
United States
Canada
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.9M
28.8M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
BAFN
BCTX
Price
$6.53
$3.79
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$40.00
AVG Volume (30 Days)
13.7K
179.7K
Earning Date
04-30-2026
01-01-0001
Dividend Yield
1.16%
N/A
EPS Growth
133.93
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$380.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.72
$0.61
52 Week High
$19.15
$14.68

Technical Indicators

Market Signals
Indicator
BAFN
BCTX
Relative Strength Index (RSI) 43.24 38.08
Support Level $6.31 $0.68
Resistance Level $8.26 $4.42
Average True Range (ATR) 0.45 0.25
MACD -0.01 0.11
Stochastic Oscillator 0.53 24.39

Price Performance

Historical Comparison
BAFN
BCTX

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: